Jason Kolbert
D. Boral Capital | Healthcare
Jason Kolbert is an analyst from D. Boral Capital specializing in the Healthcare sector. Ranked #1587 out of 4363 analysts, they have issued 471 stock ratings with a success rate of 65.29% and an average return of 32.92%.
Jason Kolbert has a well-established track record, with 471 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 65.29% and an average return of 32.92%, underscoring their expertise and ability to identify winning opportunities for investors.
Recent Ratings Analysis
KAPA
BuyOct 20, 2025
Target
$9.00
Current
$1.17
Performance
0.00%
Jason Kolbert rated KAPA as Buy on Oct 20, 2025, setting a price target of 9. Shares have remained stable near 1.17, leaving the 9 target still in play.
CRMD
BuyOct 20, 2025
Target
$14.00
Current
$12.16
Performance
0.00%
On Oct 20, 2025, CRMD was given a Buy rating by Jason Kolbert, with a target price of 14. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.
CLGN
BuyOct 20, 2025
Target
$12.00
Current
$2.49
Performance
0.00%
CLGN received a Buy rating from Jason Kolbert on Oct 20, 2025, aiming for 12. Price action was muted, as shares hovered around 2.49 despite the bullish outlook.
MSAI
BuyOct 17, 2025
Target
$3.00
Current
$0.55
Performance
9.06%
On Oct 17, 2025, Jason Kolbert published a Buy outlook on MSAI, with a target of 3. Shares gained 9.06%, underscoring the accuracy of the bullish outlook toward 3.
RCEL
BuyOct 17, 2025
Target
$14.00
Current
$4.01
Performance
0.50%
Jason Kolbert on Oct 17, 2025 assigned RCEL a Buy rating, with a price target of 14. The recommendation remains pending validation as shares consolidate around 4.01.
CODX
BuyOct 16, 2025
Target
$3.00
Current
$0.35
Performance
-1.23%
On Oct 16, 2025, Jason Kolbert reaffirmed CODX with a Buy rating, targeting 3. Market indecision has kept the 3 target in a holding pattern.
OMER
BuyOct 16, 2025
Target
$36.00
Current
$8.25
Performance
-16.07%
OMER was rated Buy by Jason Kolbert on Oct 16, 2025, with a price objective of 36. This case shows how bullish projections can fail, with the stock now below 8.25.
CNTX
BuyOct 16, 2025
Target
$9.00
Current
$1.37
Performance
8.73%
On Oct 16, 2025, Jason Kolbert initiated coverage on CNTX with a Buy rating and target of 9. The stock’s climb of 8.73% since the call highlights the foresight in the rating.
HOVR
BuyOct 15, 2025
Target
$11.00
Current
$2.92
Performance
-19.34%
Jason Kolbert issued a Buy recommendation for HOVR on Oct 15, 2025, price target set at 11. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.
VERI
BuyOct 15, 2025
Target
$25.00
Current
$6.10
Performance
-27.29%
On Oct 15, 2025, VERI was evaluated by Jason Kolbert, who gave a Buy rating and target of 25. Investors saw limited payoff as shares fell short of the 25 target.
MDCX
BuyOct 14, 2025
Target
$27.00
Current
$2.49
Performance
4.62%
Jason Kolbert rated MDCX as Buy on Oct 14, 2025, setting a price target of 27. Shares have remained stable near 2.49, leaving the 27 target still in play.
CERO
BuyOct 13, 2025
Target
$30.00
Current
$2.40
Performance
-27.93%
On Oct 13, 2025, CERO was given a Buy rating by Jason Kolbert, with a target price of 30. Despite the Buy call, shares fell from 2.4 to 2.4, challenging the optimistic stance.
OSTX
BuyOct 10, 2025
Target
$20.00
Current
$1.83
Performance
-8.04%
OSTX received a Buy rating from Jason Kolbert on Oct 10, 2025, aiming for 20. The rating hasn’t played out as hoped, with the stock trading 8.04% below expectations.
BMEA
BuyOct 07, 2025
Target
$16.00
Current
$1.60
Performance
-13.51%
On Oct 07, 2025, Jason Kolbert published a Buy outlook on BMEA, with a target of 16. Market action contradicted the Buy thesis, as shares slipped to 1.6.
ANIX
BuyOct 07, 2025
Target
$10.00
Current
$4.29
Performance
4.38%
Jason Kolbert on Oct 07, 2025 assigned ANIX a Buy rating, with a price target of 10. The recommendation remains pending validation as shares consolidate around 4.29.
HUMA
BuyOct 06, 2025
Target
$25.00
Current
$1.81
Performance
-27.02%
On Oct 06, 2025, Jason Kolbert reaffirmed HUMA with a Buy rating, targeting 25. Shares slid 27.02% despite the recommendation, highlighting downside risks.
IVVD
BuyOct 06, 2025
Target
$2.00
Current
$1.97
Performance
38.73%
IVVD was rated Buy by Jason Kolbert on Oct 06, 2025, with a price objective of 2. A bullish response from the market helped close the gap of 0.03 to the target.
URGN
BuyOct 03, 2025
Target
$25.00
Current
$18.00
Performance
3.42%
On Oct 03, 2025, Jason Kolbert initiated coverage on URGN with a Buy rating and target of 25. Neutral price movement of 3.42% leaves room for interpretation.
AVXL
BuyOct 02, 2025
Target
$46.00
Current
$9.36
Performance
2.52%
Jason Kolbert issued a Buy recommendation for AVXL on Oct 02, 2025, price target set at 46. The target of 46 remains in play, though confirmation will depend on future moves.
COYA
BuySep 29, 2025
Target
$18.00
Current
$6.41
Performance
13.25%
On Sep 29, 2025, COYA was evaluated by Jason Kolbert, who gave a Buy rating and target of 18. This case illustrates how a timely bullish rating can translate into tangible gains of 13.25%.
VNRX
BuySep 29, 2025
Target
$5.00
Current
$0.45
Performance
-28.14%
Jason Kolbert rated VNRX as Buy on Sep 29, 2025, setting a price target of 5. The stock has underperformed, dropping 28.14% despite the bullish target of 5.
NRXP
BuySep 29, 2025
Target
$34.00
Current
$3.31
Performance
1.85%
On Sep 29, 2025, NRXP was given a Buy rating by Jason Kolbert, with a target price of 34. The stock traded sideways with a 1.85% move, keeping the bullish thesis unresolved.
QNCX
BuySep 26, 2025
Target
$4.00
Current
$1.85
Performance
14.91%
QNCX received a Buy rating from Jason Kolbert on Sep 26, 2025, aiming for 4. Momentum has favored the Buy call, with shares climbing from 1.85 to 1.85, rewarding those who trusted the recommendation.
GOVX
BuySep 26, 2025
Target
$9.00
Current
$0.60
Performance
-7.51%
On Sep 26, 2025, Jason Kolbert published a Buy outlook on GOVX, with a target of 9. Market action contradicted the Buy thesis, as shares slipped to 0.5976.
ENLV
BuySep 26, 2025
Target
$13.00
Current
$1.06
Performance
2.91%
Jason Kolbert on Sep 26, 2025 assigned ENLV a Buy rating, with a price target of 13. The recommendation remains pending validation as shares consolidate around 1.06.
CLNN
BuySep 25, 2025
Target
$23.00
Current
$8.16
Performance
38.78%
On Sep 25, 2025, Jason Kolbert reaffirmed CLNN with a Buy rating, targeting 23. The recommendation was supported by strong follow-through as the stock rose from 8.16 to 8.16.
IMUX
BuySep 25, 2025
Target
$10.00
Current
$0.84
Performance
-6.89%
IMUX was rated Buy by Jason Kolbert on Sep 25, 2025, with a price objective of 10. This case shows how bullish projections can fail, with the stock now below 0.8364.
PSTV
BuySep 25, 2025
Target
$5.00
Current
$0.58
Performance
2.90%
On Sep 25, 2025, Jason Kolbert initiated coverage on PSTV with a Buy rating and target of 5. Neutral price movement of 2.90% leaves room for interpretation.
MNOV
BuySep 22, 2025
Target
$9.00
Current
$1.21
Performance
-5.47%
Jason Kolbert issued a Buy recommendation for MNOV on Sep 22, 2025, price target set at 9. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.
RVPH
BuySep 19, 2025
Target
$2.00
Current
$0.54
Performance
100.79%
On Sep 19, 2025, RVPH was evaluated by Jason Kolbert, who gave a Buy rating and target of 2. This case illustrates how a timely bullish rating can translate into tangible gains of 100.79%.
NNOX
BuySep 19, 2025
Target
$8.00
Current
$4.22
Performance
6.30%
Jason Kolbert rated NNOX as Buy on Sep 19, 2025, setting a price target of 8. The call has proven timely, with shares rising 6.30% toward the price target of 8.
EVTL
BuySep 18, 2025
Target
$15.00
Current
$4.93
Performance
-5.01%
On Sep 18, 2025, EVTL was given a Buy rating by Jason Kolbert, with a target price of 15. Despite the Buy call, shares fell from 4.93 to 4.93, challenging the optimistic stance.
CANF
BuySep 16, 2025
Target
$11.00
Current
$0.52
Performance
-20.22%
CANF received a Buy rating from Jason Kolbert on Sep 16, 2025, aiming for 11. The rating hasn’t played out as hoped, with the stock trading 20.22% below expectations.
CTSO
BuySep 16, 2025
Target
$10.00
Current
$0.85
Performance
-6.50%
On Sep 16, 2025, Jason Kolbert published a Buy outlook on CTSO, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 0.85.
AREC
BuySep 15, 2025
Target
$6.00
Current
$4.73
Performance
93.06%
Jason Kolbert on Sep 15, 2025 assigned AREC a Buy rating, with a price target of 6. The Buy call aligned well with market performance, producing a gain of 93.06%.
FBLG
BuySep 10, 2025
Target
$16.00
Current
$0.41
Performance
-24.51%
On Sep 10, 2025, Jason Kolbert reaffirmed FBLG with a Buy rating, targeting 16. Shares slid 24.51% despite the recommendation, highlighting downside risks.
LUNG
BuySep 08, 2025
Target
$16.00
Current
$1.67
Performance
-1.76%
LUNG was rated Buy by Jason Kolbert on Sep 08, 2025, with a price objective of 16. The stock is in a wait-and-see zone, leaving the Buy case open-ended.
ARTL
HoldSep 08, 2025
Target
$0.00
Current
$3.88
Performance
-14.73%
On Sep 08, 2025, Jason Kolbert initiated coverage on ARTL with a Hold rating and target of null. The rating matched the stock’s inability to hold above 3.88.
IBRX
BuySep 08, 2025
Target
$24.00
Current
$2.45
Performance
1.66%
Jason Kolbert issued a Buy recommendation for IBRX on Sep 08, 2025, price target set at 24. The target of 24 remains in play, though confirmation will depend on future moves.
TVGN
BuySep 04, 2025
Target
$10.00
Current
$0.70
Performance
-20.24%
On Sep 04, 2025, TVGN was evaluated by Jason Kolbert, who gave a Buy rating and target of 10. Investors saw limited payoff as shares fell short of the 10 target.
MVIS
BuySep 02, 2025
Target
$3.00
Current
$1.19
Performance
4.39%
Jason Kolbert rated MVIS as Buy on Sep 02, 2025, setting a price target of 3. Shares have remained stable near 1.19, leaving the 3 target still in play.
LCTX
BuyAug 27, 2025
Target
$2.00
Current
$1.64
Performance
34.43%
On Aug 27, 2025, LCTX was given a Buy rating by Jason Kolbert, with a target price of 2. The stock rallied 34.43% after the rating, narrowing the gap to the target of 2 and validating the bullish stance.
XAIR
BuyAug 21, 2025
Target
$11.00
Current
$2.44
Performance
18.45%
XAIR received a Buy rating from Jason Kolbert on Aug 21, 2025, aiming for 11. Momentum has favored the Buy call, with shares climbing from 2.44 to 2.44, rewarding those who trusted the recommendation.
CRVO
BuyAug 18, 2025
Target
$31.00
Current
$7.51
Performance
-23.60%
On Aug 18, 2025, Jason Kolbert published a Buy outlook on CRVO, with a target of 31. Market action contradicted the Buy thesis, as shares slipped to 7.51.
HOTH
BuyAug 18, 2025
Target
$5.00
Current
$1.39
Performance
7.75%
Jason Kolbert on Aug 18, 2025 assigned HOTH a Buy rating, with a price target of 5. The Buy call aligned well with market performance, producing a gain of 7.75%.
NRSN
BuyAug 15, 2025
Target
$14.00
Current
$1.25
Performance
5.04%
On Aug 15, 2025, Jason Kolbert reaffirmed NRSN with a Buy rating, targeting 14. The recommendation was supported by strong follow-through as the stock rose from 1.25 to 1.25.
CTXR
BuyAug 13, 2025
Target
$6.00
Current
$1.81
Performance
41.41%
CTXR was rated Buy by Jason Kolbert on Aug 13, 2025, with a price objective of 6. A bullish response from the market helped close the gap of 4.19 to the target.
CMPX
BuyAug 12, 2025
Target
$32.00
Current
$4.05
Performance
27.76%
On Aug 12, 2025, Jason Kolbert initiated coverage on CMPX with a Buy rating and target of 32. The stock’s climb of 27.76% since the call highlights the foresight in the rating.
ESLA
BuyAug 12, 2025
Target
$16.00
Current
$1.99
Performance
130.06%
Jason Kolbert issued a Buy recommendation for ESLA on Aug 12, 2025, price target set at 16. Investors following the Buy call captured upside momentum, with shares now at 1.99.
CARM
BuyAug 08, 2025
Target
$1.00
Current
$0.04
Performance
-86.33%
On Aug 08, 2025, CARM was evaluated by Jason Kolbert, who gave a Buy rating and target of 1. Investors saw limited payoff as shares fell short of the 1 target.
SCLX
BuyApr 02, 2025
Target
$18.00
Current
$14.09
Performance
35.31%
Jason Kolbert rated SCLX as Buy on Apr 02, 2025, setting a price target of 18. The call has proven timely, with shares rising 35.31% toward the price target of 18.
CKPT
BuyMar 31, 2025
Target
$4.80
Current
$4.26
Performance
5.45%
On Mar 31, 2025, CKPT was given a Buy rating by Jason Kolbert, with a target price of 4.8. The stock rallied 5.45% after the rating, narrowing the gap to the target of 4.8 and validating the bullish stance.
IMNN
BuyMar 24, 2025
Target
$29.00
Current
$5.02
Performance
-68.72%
IMNN received a Buy rating from Jason Kolbert on Mar 24, 2025, aiming for 29. The rating hasn’t played out as hoped, with the stock trading 68.72% below expectations.
TRVI
BuyMar 19, 2025
Target
$21.00
Current
$10.69
Performance
56.98%
On Mar 19, 2025, Jason Kolbert published a Buy outlook on TRVI, with a target of 21. Shares gained 56.98%, underscoring the accuracy of the bullish outlook toward 21.
ANVS
HoldFeb 10, 2025
Target
$0.00
Current
$2.07
Performance
-24.45%
Jason Kolbert on Feb 10, 2025 assigned ANVS a Hold rating, with a price target of null. The call successfully avoided chasing as shares lost 24.45%.
MRNS
BuyNov 13, 2024
Target
$3.00
Current
$0.55
Performance
81.94%
On Nov 13, 2024, Jason Kolbert reaffirmed MRNS with a Buy rating, targeting 3. The recommendation was supported by strong follow-through as the stock rose from 0.55 to 0.55.
LUMO
BuySep 24, 2024
Target
$16.00
Current
$4.34
Performance
10.71%
LUMO was rated Buy by Jason Kolbert on Sep 24, 2024, with a price objective of 16. A bullish response from the market helped close the gap of 11.66 to the target.